"Pfizer Aims for End-of-Month Authorization of Updated Covid Boosters"

Pfizer CEO Albert Bourla stated that the FDA could authorize updated Covid boosters by the end of August. The boosters are designed to target the XBB.1.5 subvariant, which was previously advised by the FDA. Although XBB.1.5 is no longer the predominant strain, accounting for 12.3% of new cases, Bourla expects a new Covid wave to start in the U.S. this fall. The decision on recommending boosters for everyone will be made by the CDC after FDA authorization. Currently, only 17% of the U.S. population has received an updated booster.